# SBRT Pre-operatively for Pancreatic Cancer

> **NCT02308722** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 12 (actual)

## Conditions studied

- Pancreatic Neoplasms

## Interventions

- **RADIATION:** 5-fraction stereotactic body radiation therapy

## Key facts

- **NCT ID:** NCT02308722
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-10-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02308722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02308722, "SBRT Pre-operatively for Pancreatic Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02308722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*